2627.HK
AB&B BIO-TECH-B
HK$29.32
+0.00%
2026-05-29
About AB&B BIO-TECH-B
Ab&B Bio-Tech CO., LTD. JS researchs, develops, manufactures, and sells vaccines and biological preparations that provide active immunity against diseases. The company offers various vaccines, such as human rabies vaccine, pneumococcal vaccine, zoster vaccine, respiratory syncytial virus vaccine, mpox vaccine, varicella vaccine, and tetanus vaccine. The company was founded in 2015 and is based in Taizhou, China.
Key Fundamentals
EPS (TTM)
HK$-0.66
Revenue Growth (YoY)
959.8%
Profit Margin
-69.3%
Debt/Equity
2722.95
Price/Book
272.81
Market Cap
HK$11.54B
Avg Volume (10D)
Recent Breakout Signals
No recent breakout signals detected for 2627.HK.
Recent Price Range (60 Days)
60D High
HK$73.00
60D Low
HK$28.88
Avg Volume
472K
Latest Close
HK$29.32
Get breakout alerts for 2627.HK
Sign up for Breakout Scanner to receive daily notifications when 2627.HK triggers breakout signals. Build custom AI screeners and backtest strategies.
Start Free Trial7-day free trial.
AB&B BIO-TECH-B (2627.HK) is listed on the Hong Kong Exchanges (HKEX). Breakout Scanner monitors 2627.HK daily for breakout patterns including long-term ceiling breakouts, momentum breakouts, and near-breakout watch setups. 2627.HK operates in the Healthcare sector within the Drug Manufacturers - Specialty & Generic industry. Data is provided for informational purposes only and does not constitute financial advice.